Heart News and Research

RSS

NeuroVive, Selcia sign research collaboration agreement to develop new mitochondrial drugs

UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology.

19 Sep 2011

Noninvasive method can detect sudden infant death syndrome, sleep apnea

University of Utah engineers who built wireless networks that see through walls now are aiming the technology at a new goal: noninvasively measuring the breathing of surgery patients, adults with sleep apnea and babies at risk of sudden infant death syndrome.

19 Sep 2011

Cornell researchers learn how helicase enzyme works to unzip two strands of DNA

With an eye toward understanding DNA replication, Cornell researchers have learned how a helicase enzyme works to actually unzip the two strands of DNA.

19 Sep 2011

HFSA scientific meeting to discuss long-term management care for LVAD patients

The 15th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will feature a discussion by Laura Coyle, ACNP, on strategies for caring for LVAD patients in an outpatient setting entitled "Long-Term Management: Caring for Patients to Keep Them at Home."

19 Sep 2011

ACC cardiologist to address the United Nations Summit on Non-Communicable Diseases

Cardiologist William Zoghbi, M.D., will address the United Nations Summit on Non-Communicable Diseases next week to argue that abating heart disease should be a target of the United Nations' eight Millennium Development Goals.

19 Sep 2011

Research roundup: Personalized info helps consumer decision-making; Racial disparities in knee replacement

Comparison Friction: Experimental Evidence From Medicare Drug Plans – Defining comparison friction as "the wedge between the availability of comparative information and consumers' use of it," the authors determined that providing prescription drug pricing information, even though it was free and accessible in other ways, increased the amount of "plan-switching" in the group to 28 percent compared to 17 percent in another that did not get the individual information.

17 Sep 2011

Power wheelchairs are not 'government waste', they give freedom and independence to people with disabilities

"The public would be better served if policymakers left their desks in Washington and met with us in our homes, where every day is a struggle."

17 Sep 2011

Researchers show how protein fortilin promotes growth of cancer cells

Researchers have shown for the first time that the protein fortilin promotes growth of cancer cells by binding to and rendering inert protein p53, a known tumor suppressor. This finding by researchers at the University of Texas Medical Branch may lead to treatments for a range of cancers and atherosclerosis, which p53 also helps prevent, and appears in the current print issue of the Journal of Biological Chemistry.

17 Sep 2011

Harvard’s own ‘Healthy Eating Plate’ as an improvement upon USDA’s MyPlate

A few months earlier the United States Department of Agriculture unveiled ‘MyPlate’, the replacement for the food pyramid. Now the Harvard School of Public Health says that MyPlate doesn't offer enough about good nutrition, and they have offered their own version.

16 Sep 2011

Two reports reveal sad state of affairs in some UK hospitals

Nurses at some institutions are serving up people’s evening meals at 3pm – just because it is more convenient, inspectors found. And several hospitals do not have enough nurses on wards to feed or wash patients, or help move them to prevent bedsores. Nurses arrive unannounced at elderly patients’ bedsides and strap blood pressure monitors round their arms without telling them what they are doing.

16 Sep 2011

Anti-nausea drug Zofran being tested for its potential heart rhythm side effects

The United States health regulators Food and Drug Administration (FDA) are looking at the safety of GlaxoSmithKline's anti-nausea drug Zofran generically known as ondansetron, to ascertain whether there is a potential risk of abnormal heart rhythm.

16 Sep 2011

Dr. Oz and apple juice – FDA and experts fume at arsenic false alarm

Television's Dr. Mehmet Oz is being questioned by the Food and Drug Administration (FDA) and others for sounding what they say is a false alarm about the dangers of apple juice.

16 Sep 2011

ONGLYZA used with insulin maintains improvement in glucose control in adults with type 2 diabetes

Bristol-Myers Squibb Company and AstraZeneca today announced results from an investigational Phase 3b clinical study in which the addition of ONGLYZA (saxagliptin) 5 mg to ongoing insulin therapy (with or without metformin) maintained reductions of blood sugar levels (glycosylated hemoglobin levels, or HbA1c) in adult patients with type 2 diabetes compared to the addition of placebo (with or without metformin) from 24 to 52 weeks.

16 Sep 2011

Advocates ramp up efforts to protect Medicaid from 'super committee' trims

State Medicaid directors as well as patient and consumer advocates are detailing the harms that would result from various Medicaid changes under discussion.

16 Sep 2011

Policies needed to prepare individuals, society for earlier diagnosis and high risk of Alzheimer's

The changing tide of Alzheimer's diagnosis presents new challenges to the public, physicians and lawmakers: if you could find out your Alzheimer's risk, would you want to know? How should doctors tell you your risk? And what does it mean for the many newly diagnosed Americans still in the workplace?

16 Sep 2011